Namenda and Eczema - a phase IV clinical study of FDA data

Summary:

Eczema is reported as a side effect among people who take Namenda (memantine hydrochloride), especially for people who are female, 60+ old, also take Metoclopramide, and have Lung cancer - non-small cell.

The phase IV clinical study analyzes which people have Eczema when taking Namenda. It is created by eHealthMe based on reports of 13,521 people who have side effects when taking Namenda from the FDA, and is updated regularly.

What is Namenda?

Namenda has active ingredients of memantine hydrochloride. It is often used in dementia. eHealthMe is studying from 14,283 Namenda users. Check the latest studies of Namenda.

What is Eczema?

Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters) is found to be associated with 1,480 drugs and 1,947 conditions by eHealthMe. Check the latest studies of Eczema.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

13,521 people reported to have side effects when taking Namenda.
Among them, 12 people (0.09%) have Eczema.

Among these 12 people:

What is the gender of people who have Eczema when taking Namenda? *

female: 58.33 %
male: 41.67 %

What is the age of people who have Eczema when taking Namenda? *

What are other drugs people take besides Namenda? *

What are other side effects people have besides Eczema? *

Nausea And Vomiting: 4 people, 33.33%
Cough: 3 people, 25.00%
Fall: 2 people, 16.67%
Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it): 2 people, 16.67%
Diarrhea: 2 people, 16.67%
Dry Skin: 2 people, 16.67%
Urticaria (rash of round, red welts on the skin that itch intensely): 2 people, 16.67%
Adverse Drug Reaction: 2 people, 16.67%
Oedema (fluid collection in tissue): 2 people, 16.67%
Rash Erythematous (redness of the skin): 2 people, 16.67%

What are the existing conditions these people have? *

Lung Carcinoma Cell Type Unspecified Stage Iv (the lung cancer has spread to other organs of the body, such as the other lung, brain, or liver): 4 people, 33.33%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 33.33%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 16.67%
Lung Neoplasm (tumour of lung): 2 people, 16.67%
Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 2 people, 16.67%
Dementia Alzheimer's Type (loss of mental ability with alzheimer's symptom): 2 people, 16.67%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 16.67%
Bronchial Neoplasm (bronchial tumour): 2 people, 16.67%
Stress And Anxiety: 1 person, 8.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 1 person, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Namenda and have Eczema?

- Check whether Eczema is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Namenda:

Namenda (14,283 reports)

Eczema treatments and more:

Eczema (61,311 reports)

Browse all side effects of Namenda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eczema:

Eczema (1,480 drugs)

Browse all the conditions that are associated with Eczema:

Eczema (1,947 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on memantine hydrochloride (the active ingredients of Namenda) and Namenda (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.